Inventor · disambiguated record
Stewart A. Noble
Also filed as: NOBLE STEWART · NOBLE STEWART A · NOBLE STEWART ALWYN
29 granted patents·27 pending applications·410 citations·filing 1981–2022
97Inventor score
Top patents by PatentIndex Score
56 records- 0195US6340683B1Selective NPY (Y5) antagonists (triazines)SYNAPTIC PHARMA CORP·Filed 1999·Granted Jan 22, 2002·97 cites·29 claims
- 0294US6720324B2Selective melanin concentrating hormone-1 (MCH1) receptor antagonists and uses thereofSYNAPTIC PHARMA CORP·Filed 2001·Granted Apr 13, 2004·51 cites·18 claims
- 0393US7273880B2Selective NPY (Y5) antagonistsNOVARTIS AG·Filed 2005·Granted Sep 25, 2007·20 cites·1 claims
- 0492US8080566B1Carbazole inhibitors of histamine receptors for the treatment of diseaseKAHRAMAN MEHMET·Filed 2009·Granted Dec 20, 2011·14 cites·10 claims
- 0592US7470722B2Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of diseaseKALYPSYS INC·Filed 2005·Granted Dec 30, 2008·25 cites·43 claims
- 0687US7381749B2Sulfonamides as inhibitors of histone deacetylase for the treatment of diseaseKALYPSYS INC·Filed 2005·Granted Jun 3, 2008·10 cites·30 claims
- 0787US6218408B1Selective NPY (Y5) antagonists (bicyclics)SYNAPTIC PHARMA CORP·Filed 1999·Granted Apr 17, 2001·43 cites·26 claims
- 0886US7745646B2Bicyclic heteroaryl inhibitors of PDE4KALYPSYS INC·Filed 2007·Granted Jun 29, 2010·7 cites·22 claims
- 0984US8569300B2Substituted tetrazolo[1,5-A]pyrazine inhibitors of histamine receptors for the treatment of diseaseBORCHARDT ALLEN·Filed 2011·Granted Oct 29, 2013·14 cites·17 claims
- 1082US7494999B2Sulfonyl-substituted bicyclic compounds as modulators of PPARKALYPSYS INC·Filed 2005·Granted Feb 24, 2009·6 cites·9 claims
- 1182US6124331ASelective NPY (Y5) antagonists (tricyclics)SYNAPTIC PHARMA CORP·Filed 1999·Granted Sep 26, 2000·31 cites·21 claims
- 1281US8138205B2Heteroarylalkoxy-substituted quinolone inhibitors of PDE4GOVEK STEVEN P·Filed 2009·Granted Mar 20, 2012·4 cites·19 claims
- 1380US6569856B2Selective NPY (Y5) antagonists (triazines)SYNAPTIC PHARMA CORP·Filed 2002·Granted May 27, 2003·10 cites·27 claims
- 1477US6225330B1Selective NPY (Y5) antagonists (tricyclics)SYNAPTIC PHARMA CORP·Filed 1999·Granted May 1, 2001·22 cites·23 claims
- 1576US6214853B1Selective NPY (Y5) antagonists (bicyclics)SYNAPTIC PHARMA CORP·Filed 1999·Granted Apr 10, 2001·23 cites·16 claims
- 1674US8080563B2Bicyclic heteroaryl inhibitors of PDE4GOVEK STEVEN P·Filed 2007·Granted Dec 20, 2011·1 cites·7 claims
- 1771US7834004B2Sulfonyl-substituted bicyclic compounds as modulators of PPARKALYPSYS INC·Filed 2008·Granted Nov 16, 2010·1 cites·37 claims
- 1868US8258154B2Bicyclic heteroaryl inhibitors of PDE4GOVEK STEVEN·Filed 2007·Granted Sep 4, 2012·1 cites·13 claims
- 1965US2010094021A1Novel method of preparation of 5-chloro-3-imidazol-1-yl-[1,2,4]thiadiazole and (3-imidazol-1-yl-[1,2,4]thiadiazol-5yl)-dialkyl-aminesKALYPSYS INC·Filed 2009·Application pending·0 cites
- 2062US2009227599A1Sulfonyl-substituted bicyclic compounds as modulators of pparKALYPSYS INC·Filed 2009·Application pending·0 cites
- 2160US12291708B2Oral delivery of antisense conjugates targeting PCSK9CIVI BIOPHARMA INC·Filed 2021·Granted May 6, 2025·0 cites·14 claims
- 2260US4383990AAntiviral agents, their preparation and useBEECHAM GROUP LTD·Filed 1981·Granted May 17, 1983·7 cites·11 claims
- 2359US7915253B2Sulfonyl-substituted bicyclic compounds as modulators of PPARKALYPSYS INC·Filed 2008·Granted Mar 29, 2011·0 cites·40 claims
- 2459US6989379B1Selective NPY (Y5) antagonistsLUNDBICK AS H·Filed 2000·Granted Jan 24, 2006·4 cites·29 claims
- 2559US6222040B1Selective NPY (Y5) antagonists (tricyclics)SYNAPTIC PHARMA CORP·Filed 1999·Granted Apr 24, 2001·8 cites·21 claims
- 2658US9078887B2Bicyclic heteroaryl inhibitors of PDE4GOVEK STEVEN P·Filed 2012·Granted Jul 14, 2015·0 cites·17 claims
- 2757US2010105729A1Aryl-substituted heterocyclic pde4 inhibitors as anti-inflammatory agentsKALYPSYS INC·Filed 2007·Application pending·0 cites
- 2857US2007123572A1Novel method of preparation of 5-chloro-3-imidazol-1-yl-[1,2,4]thiadiazole and (3-imidazol-1-yl-[1,2,4]thiadiazol-5yl)-dialkyl-aminesKALYPSYS INC·Filed 2006·Application pending·0 cites
- 2957US2009275586A1Heterocyclic inhibitors of pde4KALYPSYS INC·Filed 2007·Application pending·0 cites
- 3056US7271195B2Carbonyl compounds as inhibitors of histone deacetylase for the treatment of diseaseKALYPSYS INC·Filed 2004·Granted Sep 18, 2007·1 cites·10 claims
- 3156US2009318485A1Novel inhibitors of rho kinaseKALYPSYS INC·Filed 2007·Application pending·0 cites
- 3253US2008021026A1Benzothiophene inhibitors of rho kinaseKAHRAMAN MEHMET·Filed 2007·Application pending·0 cites
- 3353US2008021217A1Heterocyclic inhibitors of rho kinaseBORCHARDT ALLEN J·Filed 2007·Application pending·0 cites
- 3453US2007190079A1Methods for the selective modulation of pparKALYPSYS INC·Filed 2007·Application pending·0 cites
- 3553US2008045524A1Selective NPY (Y5) antagonistsLUNDBECK & CO AS H·Filed 2007·Application pending·0 cites
- 3652US6090825AOxazole derivatives as antagonists of alpha 1C andrenergic receptorsGLAXO WELLCOME INC·Filed 1995·Granted Jul 18, 2000·10 cites·14 claims
- 3752US2006252807A1Novel ortho-terphenyl inhibitors of p38 kinase and methods of treating inflammatory disordersKALYPSYS INC·Filed 2006·Application pending·0 cites
- 3852US2004106623A1Compounds specific for the human alpha1d adrenergic receptor and uses thereofSYNAPTIC PHARMA CORP·Filed 2003·Application pending·0 cites
- 3950US2022380761A1Oral delivery of oligonucleotidesCIVI BIOPHARMA INC·Filed 2022·Application pending·0 cites
- 4049US7189720B2Selective NPY (Y5) antagonistsLUNDBECK & CO AS H·Filed 2005·Granted Mar 13, 2007·0 cites·16 claims
- 4149US2004242609A1Selective melanin concentrating hormone-1 (MCH1) receptor antagonists and uses thereofSYNAPTIC PHARMA CORP·Filed 2004·Application pending·0 cites
- 4248US2003176314A1Compounds for the treatment of painFiled 2002·Application pending·0 cites
- 4348US2003139431A1Guanidines which are agonist/antagonist ligands for neuropeptide FF (NPFF) receptorsFiled 2002·Application pending·0 cites
- 4447US2013045975A1Bicyclic heteroaryl inhibitors of pde4KALYPSYS INC·Filed 2012·Application pending·0 cites
- 4546US2009035306A1Quinazolinone modulators of tgr5KALYPSYS INC·Filed 2007·Application pending·0 cites
- 4646US2007270434A1Sulfonyl-substituted bicyclic compounds as modulators of pparKALYPSYS INC·Filed 2007·Application pending·0 cites
- 4744US2006258683A1Para-sulfonyl substituted phenyl compounds as modulators of pparsLIU KEVIN·Filed 2004·Application pending·0 cites
- 4843US2008139558A1Quinolones useful as inducible nitric oxide synthase inhibitorsKALYPSYS INC·Filed 2007·Application pending·0 cites
- 4942US2007027184A1Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of diseaseKALYPSYS INC·Filed 2006·Application pending·0 cites
- 5042US2005203151A1Novel compounds, compositions and uses thereof for treatment of metabolic disorders and related conditionsKALYPSYS INC·Filed 2004·Application pending·0 cites
Showing the top 50 of 56 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →